The online version of this article (doi:10.1186/1471-2261-14-139) contains supplementary material, which is available to authorized users.
The authors declared that they have no competing interests.
Depression is common in patients with cardiometabolic diseases but little is known about the relationship, if any, between cardiovascular risk factor values and depressive symptoms in patients with these conditions. The objective of this paper is to study the association between cardiovascular risk factors and concurrent depressive symptoms in patients with three common cardiometabolic conditions: coronary heart disease (CHD), stroke and diabetes.
We retrospectively reviewed primary care data for N = 35537 with 1 of the above 3 conditions who underwent depression screening using the depressive subscale of hospital anxiety and depression score (HADS-D). We reviewed 4 cardiometabolic risk factors (Systolic Blood Pressure [SBP], Diastolic Blood Pressure [DBP], BMI and total cholesterol) recorded concurrently in all patients and HbA1c in patients with diabetes (n = 18453). We analysed the association between individual risk factor value and a positive HADS-D screening result (>7) using logistic regression.
SBP and BMI were noted to have a non-linear “J-shaped” relationship with the probability of having a positive HADS-D and observed nadirs (levels with the lowest probability) of 148 mm Hg and 30.70 kg/m2, respectively. Total cholesterol and DBP found to have a weaker curvilinear association with concurrent depression symptoms and nadirs of 3.60 mmol/l and 74 mmHg. Among patients with Diabetes, HbA1c was also found to have a “J-shaped” relationship with probability of having a positive HADS-D with an observed nadir of 7.06% DCCT. The above relationships remain significant after adjusting for age, sex, socio-economic status and number of co-morbid conditions.
In patients with cardiometabolic disease, cardiovascular risk factor values at both extremes were associated with higher positive depression screening after adjusting for confounders. These findings have potentially important implications for clinical practice in relation to both risk stratification for depression and approaches to secondary prevention in individuals with cardiometabolic disease and merit further investigation to determine the nature and direction of the observed association.
Please see related article: http://www.biomedcentral.com/1741-7015/12/199.
Additional file 1: “Additional Analysis”. Results of sensitivity and supplementary analysi. (PDF 215 KB)
Additional file 2: “Linear Regression with HADS-D as continuous measure”. Results of statistical analysis with linear regression models using HADS-D as a continuous measure. (PDF 183 KB)
Hadidi N, Treat-Jacobson DJ, Lindquist R: Poststroke depression and functional outcome: a critical review of literature. Hear Lung. 2009, 38: 151-162. 10.1016/j.hrtlng.2008.05.002. CrossRef
Whooley MA, De JP, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD, Schiller NB, Browner WS: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008, 300: 2379-2388. 10.1001/jama.2008.711. CrossRefPubMedPubMedCentral
Larsen KK, Christensen B, Sondergaard J, Vestergaard M: Depressive Symptoms and Risk of New Cardiovascular Events or Death in Patients with Myocardial Infarction: A Population-Based Longitudinal Study Examining Health Behaviors and Health Care Interventions. PLoS One. 2013, 8: e74393-10.1371/journal.pone.0074393. CrossRefPubMedPubMedCentral
Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES: Depression and coronary heart disease: recommendations for screening, referral, and treatment. Circulation. 2008, 118: 1768-1775. 10.1161/CIRCULATIONAHA.108.190769. CrossRefPubMed
Ontario HQ: Screening and management of depression for adults with chronic diseases: an evidence-based analysis. Ont Health Technol Assess Ser. 2013, 13: 1-45.
Thombs BD, Roseman M, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein RC: Does Evidence Support the American Heart Association’s Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review. PLoS One. 2013, 8: e52654-10.1371/journal.pone.0052654. CrossRefPubMedPubMedCentral
Smolderen KG, Buchanan DM, Amin AA, Gosch K, Nugent K, Riggs L, Seavey G, Spertus JA: Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients: implications for the American Heart Association depression screening advisory. Circ Qual Outcomes. 2011, 4: 283-292. 10.1161/CIRCOUTCOMES.110.960013. CrossRef
NICE: Depression in Adults with a Chronic Physical Health Problem: Treatment and Management. 2009
Scott KM, Bruffaerts R, Simon GE, Alonso J, Angermeyer M, de Girolamo G, Demyttenaere K, Gasquet I, Haro JM, Karam E, Kessler RC, Levinson D, Medina Mora ME, Oakley Browne MA, Ormel J, Villa JP, Uda H, Von Korff M: Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes (Lond). 2008, 32: 192-200. 10.1038/sj.ijo.0803701. CrossRef
Ancelin ML, Carrire I, Boulenger JP, Malafosse A, Stewart R, Cristol JP, Ritchie K, Chaudieu I, Dupuy AM: Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (The ESPRIT Study). Biol Psychiatry. 2010, 68: 125-132. 10.1016/j.biopsych.2010.04.011. CrossRefPubMed
Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289: 2363-2369. 10.1001/jama.289.18.2363. CrossRefPubMed
Thompson R, O’Regan C, Morant S, Phillips B, Ong S: Measurement of baseline total cholesterol: new data from The Health Improvement Network (THIN) database. Prim Care Cardiovasc J. 2008, 1: 107-10.3132/pccj.2008.028. CrossRef
NICE: Depression in Adults (update). 2009
Scottish Index of Multiple Deprivation (SIMD). http://www.scotland.gov.uk/Topics/Statistics/SIMD,
Team RC: R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2012, ISBN 3-900051-07-0. http://www.R-project.org/
Niu K, Hozawa A, Awata S, Guo H, Kuriyama S, Seki T, Ohmori-Matsuda K, Nakaya N, Ebihara S, Wang Y, Tsuji I, Nagatomi R: Home blood pressure is associated with depressive symptoms in an elderly population aged 70 years and over: a population-based, cross-sectional analysis. Hypertens Res. 2008, 31: 409-416. 10.1291/hypres.31.409. CrossRefPubMed
Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP: What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TI. Circulation. 2010, 122: 2142-2151. 10.1161/CIRCULATIONAHA.109.905687. CrossRefPubMed
Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010, 362: 1575-1585. CrossRefPubMed
Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F: Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006, 368: 666-678. 10.1016/S0140-6736(06)69251-9. CrossRefPubMed
Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol. 2007, 18: 304-311. 10.1681/ASN.2006060674. CrossRefPubMed
Olson MB, Kelsey SF, Matthews KA, Bairey Merz CN, Eteiba W, McGorray SP, Cornell CE, Vido DA, Muldoon MF: Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study. J Womens Health (Larchmt). 2008, 17: 187-194. 10.1089/jwh.2007.0379. CrossRef
Van der Meer RM, Willemsen MC, Smit F, Cuijpers P: Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013, 8: CD006102- PubMed
Haddad M, Walters P, Phillips R, Tsakok J, Williams P, Mann A, Tylee A: Detecting Depression in Patients with Coronary Heart Disease: A Diagnostic Evaluation of the PHQ-9 and HADS-D in Primary Care, Findings From the UPBEAT-UK Study. PLoS One. 2013, 8: e78493-10.1371/journal.pone.0078493. CrossRefPubMedPubMedCentral
Meader N, Mitchell AJ, Chew-Graham C, Goldberg D, Rizzo M, Bird V, Kessler D, Packham J, Haddad M, Pilling S: Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. Br J Gen Pract. 2011, 61: e808-e820. 10.3399/bjgp11X613151. CrossRefPubMedPubMedCentral
- Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional study
Bhautesh Dinesh Jani
Sarah JE Barry
Frances S Mair
- BioMed Central
Neu im Fachgebiet Kardiologie
Mail Icon II